Allergy, Immunology, and ENT

Latest News

Epinephrine nasal spray now available to treat type I allergic reactions, anaphylaxis | Image Credit: © Saiful52 - © Saiful52 - stock.adobe.com.
Epinephrine nasal spray now available to treat type 1 allergic reactions, anaphylaxis

September 24th 2024

The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024.

Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP

September 13th 2024

Weekly review: Neffy pre-ordering launches, trofinetide data, and more | Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: Neffy pre-ordering launches, trofinetide data, and more

September 6th 2024

Thomas Casale, MD | Image credit: USF Health
ARS launches pre-ordering for neffy to treat type 1 allergic reactions

September 4th 2024

FDA approves neffy as first nasal spray to treat anaphylaxis | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves neffy as first nasal spray to treat anaphylaxis

August 9th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.